The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A pilot study of axicabtagene ciloleucel (axi-cel) for relapsed/refractory primary and secondary central nervous system lymphoma (PCNSL and SCNSL).
 
Lakshmi Nayak
Honoraria - Ono Pharmaceutical
Consulting or Advisory Role - BraveBio; Genmab; Kite/Gilead; Ono Pharmaceutical
Speakers' Bureau - Ono Pharmaceutical
Research Funding - AstraZeneca (Inst); Kazia Therapeutics (Inst); Merck (Inst); Ono Pharmaceutical (Inst)
Patents, Royalties, Other Intellectual Property - Wolters Kluwer/ UpToDate, Inc- Royalty
Travel, Accommodations, Expenses - Ono Pharmaceutical
 
Ugonma Nnenna Chukwueke
Stock and Other Ownership Interests - Abbott Laboratories (I); Abbvie (I); Becton Dickinson (I); Danaher (I); Johnson and Johnson (I); Medtronic (I); Novartis (I)
 
Christopher Meehan
No Relationships to Disclose
 
Robert Redd
No Relationships to Disclose
 
Sarah Hogan
No Relationships to Disclose
 
Eudocia Quant Lee
Honoraria - Medlink
Consulting or Advisory Role - Medscape
Patents, Royalties, Other Intellectual Property - Royalties from Wolter Kluwer for Up to Date, Inc
 
Austin Injae Kim
Research Funding - AstraZeneca (Inst)
 
Isabel Arrillaga-Romany
Consulting or Advisory Role - Boehringer Ingelheim; FORMA Therapeutics
Research Funding - Astex Pharmaceuticals; GlaxoSmithKline
 
J. Ricardo Ricardo McFaline Figueroa
Honoraria - Novocure
Other Relationship - Elsevier
(OPTIONAL) Uncompensated Relationships - Crimson BioPharm
 
Luis Nicolas Gonzalez Castro
Employment - Takeda (I); Teladoc
Stock and Other Ownership Interests - Takeda (I)
Consulting or Advisory Role - BMJ publishing; Elsevier; Oakstone Publishing
Research Funding - Merck (Inst)
 
Mark Alan Murakami
Research Funding - Genentech/Roche; Generate Biomedicines
Patents, Royalties, Other Intellectual Property - Patent 11844800: methods and composition for predicting and preventing relapse of acute lymphoblastic leukemia.
Travel, Accommodations, Expenses - Genentech/Roche
Other Relationship - Novartis
(OPTIONAL) Uncompensated Relationships - CancerModels.org
 
Raymond Yi-kun Huang
Consulting or Advisory Role - Agios; Nuvation Bio; Nuvation Bio; Vysioneer
Research Funding - Agios; Bristol-Meyers-Squibb
 
Ulrike Gerdemann
No Relationships to Disclose
 
James Kaminski
No Relationships to Disclose
 
Simone Filosto
Employment - Genentech/Roche (I); Kite/Gilead
Stock and Other Ownership Interests - Genentech/Roche (I); Gilead Sciences
Research Funding - Genentech/Roche (I); Kite/Gilead
Patents, Royalties, Other Intellectual Property - Patents around CD38 monoclonal antibodies for modulation of immune system in Cancer
Travel, Accommodations, Expenses - Kite/Gilead
 
Soumya Poddar
Employment - Kite, a Gilead Company
 
Mike Mattie
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Kite, a Gilead Company
Patents, Royalties, Other Intellectual Property - Kite, a Gilead company
 
Philippe Armand
Consulting or Advisory Role - ADC Therapeutics; ATB Therapeutics; Bristol-Myers Squibb; Enterome; Foresight Diagnostics; Genentech/Roche; GenMab; Merck Sharp & Dohme; Regeneron
Research Funding - Adaptive Biotechnologies; Adaptive Biotechnologies (Inst); Affimed Therapeutics (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); igm (Inst); Kite, a Gilead company (Inst); Merck Sharp & Dohme (Inst); Roche (Inst)
 
Leslie Kean
Consulting or Advisory Role - EMD Serono; Forty Seven; HiFiBiO Therapeutics
Research Funding - Bluebird Bio; Gilead Sciences; Magenta Therapeutics; Regeneron
 
Caron Alyce Jacobson
Honoraria - Abbvie; Abintus Bio; ADC Therapeutics; Appia Bio; AstraZeneca; Bristol-Myers Squibb; Caribou Biosciences; Celgene; Daiichi Sankyo/UCB Japan; ImmPACT-Bio; Ipsen; Janssen; Kite/Gilead; Miltenyi Biomedicine; MorphoSys; Novartis; Sana; Synthekine
Consulting or Advisory Role - Abbvie; Abintus Bio; ADC Therapeutics; Appia Bio; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo/UCB Japan; ImmPACT-Bio; Ipsen; Janssen; Kite/Gilead; Miltenyi Biomedicine; MorphoSys; Novartis; Sana; Synthekine
Research Funding - Kite, a Gilead company; Pfizer